Dr. Garrett Richard Roll, MD

Dr. Roll practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Roll's NPI, 1316076326, was assigned on March 5, 2007. Dr. Roll graduated from Lewis Katz School of Medicine in 2005. Dr. Roll holds California license A98536.

Dr. Roll's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Roll's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Roll to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roll practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Roll's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Roll is board certified in surgery by the American Board of Surgery. Dr. Roll is licensed in California.

Dmand AI lists abdominal hernia repair surgery, gastrointestinal obstruction, groin hernia surgery and kidney transplant among the conditions Dr. Roll treats.

CMS data shows 108 Medicare services from Dr. Roll across 4 procedure codes in 2024, for 80 Medicare patients. Medicare paid $11,822 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Roll in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 55% are also on Medicaid. Their average risk score is 6.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roll's median patient age at 59, with 45% women.

In 2024, Dr. Roll wrote 145 Medicare Part D claims for 30 patients. 73% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $153 in total drug cost. In 2023, CMS named 80 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Roll for performance year 2024, reported as part of a group. Dr. Roll accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roll as offering telehealth.

Dmand AI links 108 papers to Dr. Roll, published from 2006 to 2025. 2023 was the busiest year, with 12. The most frequent topics are Liver Transplantation, Kidney Transplantation and Living Donors. Dr. Roll has published most often in Transplantation. Dr. Roll's most frequent co-authors are Shareef Mohammed Syed, MD, Nancy L. Ascher, MD and Chris E. Freise, MD.

Dmand AI links Dr. Roll to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Acquired Immunodeficiency Syndrome, End Stage Liver Disease and Papillomavirus Infections.

CMS Open Payments shows 15 general payments to Dr. Roll from 2 drug and device companies from 2017 to 2023. Education make up the largest share, 88% of the total. Intuitive Surgical, Inc. paid the most, $12,849. It also lists 2 research payments totaling $1,016 in 2018.

Dmand AI lists 1 award for Dr. Roll. Dr. Roll serves on ASTS Vanguard Committee.

Dr. Roll graduated from Lewis Katz School of Medicine in 2005. Dr. Roll is a member of ACS, American Society of Transplant Surgeons and British Transplantation Society.

Dr. Roll is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.